Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,918,000 | 4,286,000 | 5,867,000 | 7,103,000 | 545,000 |
| Marketable Securities | 1,508,000 | 388,000 | 91,000 | 581,000 | 6,058,000 |
| Inventories | 1,750,000 | 1,636,000 | 2,119,000 | 2,250,000 | 2,206,000 |
| Other current assets | 10,584,000 | 9,161,000 | 8,310,000 | 6,235,000 | 4,317,000 |
| TOTAL | $23,760,000 | $16,152,000 | $17,082,000 | $16,936,000 | $13,770,000 |
| Non-Current Assets | |||||
| PPE Net | 7,307,000 | 7,043,000 | 8,298,000 | 7,453,000 | 6,985,000 |
| Intangibles | 22,115,000 | 22,197,000 | 21,351,000 | 4,204,000 | 2,712,000 |
| Other Non-Current Assets | 1,738,000 | 1,392,000 | 1,226,000 | 1,339,000 | 1,373,000 |
| TOTAL | $31,160,000 | $30,632,000 | $30,875,000 | $12,996,000 | $11,070,000 |
| Total Assets | $54,920,000 | $46,784,000 | $47,957,000 | $29,932,000 | $24,840,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,926,000 | 993,000 | 4,280,000 | 136,000 | 90,000 |
| Accounts payable and accrued liabilities | 8,687,000 | 3,903,000 | 3,497,000 | 3,482,000 | 3,161,000 |
| Other current liabilities | 90,000 | 6,546,000 | 5,238,000 | 4,624,000 | 2,689,000 |
| TOTAL | $17,640,000 | $13,320,000 | $15,187,000 | $9,447,000 | $6,839,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 244,000 | 10,855,000 | 10,876,000 | 1,087,000 | 1,111,000 |
| Other Non-Current Liabilities | 12,807,000 | 3,275,000 | 2,723,000 | 2,311,000 | 1,993,000 |
| TOTAL | $16,459,000 | $17,404,000 | $17,855,000 | $5,069,000 | $4,310,000 |
| Total Liabilities | $34,099,000 | $30,724,000 | $33,042,000 | $14,516,000 | $11,149,000 |
| Shareholders' Equity | |||||
| Common Shares | 363,000 | 362,000 | 364,000 | 383,000 | 395,000 |
| Retained earnings | 16,198,000 | 11,572,000 | 10,624,000 | 11,348,000 | 10,679,000 |
| Other shareholders' equity | 1,919,000 | 1,932,000 | 1,902,000 | 1,902,000 | 1,831,000 |
| TOTAL | $20,660,000 | $15,912,000 | $14,778,000 | $15,304,000 | $13,597,000 |
| Total Liabilities And Equity | $54,759,000 | $46,636,000 | $47,820,000 | $29,820,000 | $24,746,000 |